Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting a conference call today, February 10, ...
Omvoh has additional ongoing trials in Crohn's disease and UC, including studies to evaluate the long-term efficacy and safety of Omvoh in pediatric patients and adults, and a Phase 4 real-world ...
The most common side effects of Ocrevus for those with PPMS are upper respiratory tract infections, infusion reactions ... Gilenya—fingolimod hcl capsule [drug label]. Food and Drug Administration.
Oxidative stress plays a critical role in the pathogenesis of upper and lower respiratory tract diseases, such as chronic rhinosinusitis with nasal polyps (CRSwNP), allergic rhinitis (AR), and asthma ...
Purpose: Evidence on the efficacy and safety of complementary and alternative medicine (CAM) for the prevention and treatment of upper-respiratory-tract infection (URTI) in children is reviewed.
Background: Acute otitis media (AOM) often occurs as a complication of upper respiratory tract infection (URI). Objective: To describe otoscopic findings during URI, the full clinical spectrum of ...
Long-term exposure to PM2.5, PM10, NO2 and ozone (O3) air pollution is associated with more hospital admissions for lower respiratory tract infections in adults.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
In a notice published on Jan. 27, 2025, the FDA labeled this a Class I recall − the highest recall risk level issued by the agency, as it can potentially lead to death. Here's what to know about the ...
Anheuser-Busch is encouraging its distributors and partners to replace the term "domestic" with "American" when marketing beer, arguing that the term better reflects the industry's identity. In ...